Macrophage Activation Markers During Sofosbuvir-based Treatment Regimes of Chronic Hepatitis C

NCT02528461 · clinicaltrials.gov ↗

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Galactose
PROCEDURE: Gastroscopy
PROCEDURE: Liver biopsy
PROCEDURE: Fibroscan
PROCEDURE: Liver vein catheterization
DRUG: Sofosbuvir

Sponsor

University of Aarhus

Collaborators

[object Object]